- Home
- OLP vs PLRX Comparison
OLP vs PLRX Comparison
Compare OLP & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- PLRX
- Stock Information
- Founded
- OLP 1982
- PLRX 2015
- Country
- OLP United States
- PLRX United States
- Employees
- OLP N/A
- PLRX N/A
- Industry
- OLP Real Estate Investment Trusts
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- OLP Real Estate
- PLRX Health Care
- Exchange
- OLP Nasdaq
- PLRX Nasdaq
- Market Cap
- OLP 483.3M
- PLRX 89.0M
- IPO Year
- OLP N/A
- PLRX 2020
- Fundamental
- Price
- OLP $22.96
- PLRX $1.46
- Analyst Decision
- OLP
- PLRX Hold
- Analyst Count
- OLP 0
- PLRX 10
- Target Price
- OLP N/A
- PLRX $3.93
- AVG Volume (30 Days)
- OLP 58.8K
- PLRX 692.5K
- Earning Date
- OLP 11-04-2025
- PLRX 11-06-2025
- Dividend Yield
- OLP 7.82%
- PLRX N/A
- EPS Growth
- OLP N/A
- PLRX N/A
- EPS
- OLP 1.29
- PLRX N/A
- Revenue
- OLP $94,839,000.00
- PLRX N/A
- Revenue This Year
- OLP $11.08
- PLRX N/A
- Revenue Next Year
- OLP $4.64
- PLRX N/A
- P/E Ratio
- OLP $17.85
- PLRX N/A
- Revenue Growth
- OLP 7.07
- PLRX N/A
- 52 Week Low
- OLP $21.94
- PLRX $1.10
- 52 Week High
- OLP $30.45
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- OLP 47.44
- PLRX 40.86
- Support Level
- OLP $22.75
- PLRX $1.66
- Resistance Level
- OLP $23.32
- PLRX $1.85
- Average True Range (ATR)
- OLP 0.41
- PLRX 0.12
- MACD
- OLP -0.04
- PLRX -0.03
- Stochastic Oscillator
- OLP 27.07
- PLRX 2.27
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.